422 related articles for article (PubMed ID: 31387604)
1. Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8
Sanz-Ortega L; Portilla Y; Pérez-Yagüe S; Barber DF
J Nanobiotechnology; 2019 Aug; 17(1):87. PubMed ID: 31387604
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions.
Sanz-Ortega L; Rojas JM; Portilla Y; Pérez-Yagüe S; Barber DF
Front Immunol; 2019; 10():2073. PubMed ID: 31543880
[TBL] [Abstract][Full Text] [Related]
3. T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field.
Sanz-Ortega L; Rojas JM; Marcos A; Portilla Y; Stein JV; Barber DF
J Nanobiotechnology; 2019 Jan; 17(1):14. PubMed ID: 30670029
[TBL] [Abstract][Full Text] [Related]
4. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
Søndergaard H; Galsgaard ED; Bartholomaeussen M; Straten PT; Odum N; Skak K
J Immunother; 2010 Apr; 33(3):236-49. PubMed ID: 20445344
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand promotes priming of fully potent antitumor CD4(+) T cells in draining lymph nodes in the presence of apoptotic tumor cells.
Fujita N; Kagamu H; Yoshizawa H; Itoh K; Kuriyama H; Matsumoto N; Ishiguro T; Tanaka J; Suzuki E; Hamada H; Gejyo F
J Immunol; 2001 Nov; 167(10):5678-88. PubMed ID: 11698440
[TBL] [Abstract][Full Text] [Related]
7. Helper-independent, L-selectinlow CD8+ T cells with broad anti-tumor efficacy are naturally sensitized during tumor progression.
Peng L; Kjaergaard J; Plautz GE; Weng DE; Shu S; Cohen PA
J Immunol; 2000 Nov; 165(10):5738-49. PubMed ID: 11067932
[TBL] [Abstract][Full Text] [Related]
8. Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma.
Miller CH; Graham L; Bear HD
BMC Immunol; 2010 Nov; 11():54. PubMed ID: 21050466
[TBL] [Abstract][Full Text] [Related]
9. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
Inoue M; Plautz GE; Shu S
Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987
[TBL] [Abstract][Full Text] [Related]
10. Administration of 6-gingerol greatly enhances the number of tumor-infiltrating lymphocytes in murine tumors.
Ju SA; Park SM; Lee YS; Bae JH; Yu R; An WG; Suh JH; Kim BS
Int J Cancer; 2012 Jun; 130(11):2618-28. PubMed ID: 21792901
[TBL] [Abstract][Full Text] [Related]
11. Distinct in vivo CD8 and CD4 T cell responses against normal and malignant tissues.
Coe D; Addey C; White M; Harwood N; Dyson J; Chai JG
Cancer Immunol Immunother; 2013 Jan; 62(1):101-12. PubMed ID: 22806093
[TBL] [Abstract][Full Text] [Related]
12. Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model.
Martin ML; Wall EM; Sandwith E; Girardin A; Milne K; Watson PH; Nelson BH
Breast Cancer Res Treat; 2010 Jun; 121(3):753-63. PubMed ID: 19789976
[TBL] [Abstract][Full Text] [Related]
13. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors.
Thompson ED; Enriquez HL; Fu YX; Engelhard VH
J Exp Med; 2010 Aug; 207(8):1791-804. PubMed ID: 20660615
[TBL] [Abstract][Full Text] [Related]
14. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model.
Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK
Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045
[TBL] [Abstract][Full Text] [Related]
15. ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes.
Yanguas A; Garasa S; Teijeira Á; Aubá C; Melero I; Rouzaut A
Front Immunol; 2018; 9():2084. PubMed ID: 30258446
[TBL] [Abstract][Full Text] [Related]
16. Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression.
Kjaergaard J; Shu S
J Immunol; 1999 Jul; 163(2):751-9. PubMed ID: 10395667
[TBL] [Abstract][Full Text] [Related]
17. In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors.
Torcellan T; Hampton HR; Bailey J; Tomura M; Brink R; Chtanova T
Proc Natl Acad Sci U S A; 2017 May; 114(22):5677-5682. PubMed ID: 28507145
[TBL] [Abstract][Full Text] [Related]
18. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors.
Helmich BK; Dutton RW
J Immunol; 2001 Jun; 166(11):6500-8. PubMed ID: 11359800
[TBL] [Abstract][Full Text] [Related]
19. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
Kilinc MO; Gu T; Harden JL; Virtuoso LP; Egilmez NK
J Immunol; 2009 Apr; 182(7):4217-25. PubMed ID: 19299720
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction.
Palmer DC; Balasubramaniam S; Hanada K; Wrzesinski C; Yu Z; Farid S; Theoret MR; Hwang LN; Klebanoff CA; Gattinoni L; Goldstein AL; Yang JC; Restifo NP
J Immunol; 2004 Dec; 173(12):7209-16. PubMed ID: 15585842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]